跳至主要内容
临床试验/IRCT20230318057749N1
IRCT20230318057749N1已完成2 期

The effect of Silymarin on the level of lipid profile and fasting blood sugar and HbA1c in patients with type 2 diabetes.

Islamic Azad University0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 68 years(—)
性别
All

入选标准

  • Patients with type 2 diabetes referring to the clinic of the Endocrine Research Institute of Iran University of Medical Sciences
  • Age group 30-68 years
  • Fasting plasma sugar more than 126 mg/dl
  • Duration of the onset of the disease more than 2 years

排除标准

  • Pregnant and lactating women
  • People less than 30 years old
  • Following a special diet
  • Suffering from cardiovascular disease, infectious diseases, kidney disease, thyroid disease
  • Treatment with Sealy Marine in 30 days before the study
  • Using chemical drugs and herbal supplements and nutritional supplements
  • Insulin therapy

研究者

相似试验